Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 81 entries
Sorted by: Best Match Show Resources per page
First-year STEM retention strategies at the University of La Verne

Minority serving Institution STEM training

Broussard C, Weaver KF.
GSID: 2S5MvrrwYO8J
KF Weaver, JV Garcia, C Broussard - Peer Review, 2015 - go.gale.com

… to help other institutions. The desire to improve STEM education at La Veme came from the mission of the institution to serve the community, including better serving our own students. …

Cite
Weaver, K. F., Garcia, J. V., & Broussard, C. (2015). First-year STEM retention strategies at the University of La Verne. Peer Review, 17(2), 21-25.
Weaver, Kathleen F., Jerome V. Garcia, and Christine Broussard. "First-year STEM retention strategies at the University of La Verne." Peer Review 17.2 (2015): 21-25.
Copy Download .nbib Format: MLA
Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000-2007: Results of EUROCARE-5 population-based study.

European journal of cancer (Oxford, England : 1990)

De Angelis R, Minicozzi P, Sant M, Dal Maso L, Brewster DH, Osca-Gelis G, Visser O, Maynadié M, Marcos-Gragera R, Troussard X, Agius D, Roazzi P, Meneghini E, Monnereau A.
PMID: 26421827
Eur J Cancer. 2015 Oct;51(15):2254-2268. doi: 10.1016/j.ejca.2015.08.003. Epub 2015 Sep 26.

BACKGROUND: Significant advances in the management of patients with lymphoid and myeloid malignancies entered clinical practice in the early 2000's. The EUROCARE-5 study database provides an opportunity to assess the impact of these changes at the population level by...

Cite
De Angelis R, Minicozzi P, Sant M, et al. Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000-2007: Results of EUROCARE-5 population-based study. Eur J Cancer. 2015;51(15):2254-2268doi: 10.1016/j.ejca.2015.08.003.
De Angelis, R., Minicozzi, P., Sant, M., Dal Maso, L., Brewster, D. H., Osca-Gelis, G., Visser, O., Maynadié, M., Marcos-Gragera, R., Troussard, X., Agius, D., Roazzi, P., Meneghini, E., Monnereau, A. (2015). Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000-2007: Results of EUROCARE-5 population-based study. European journal of cancer (Oxford, England : 1990), 51(15), 2254-2268. https://doi.org/10.1016/j.ejca.2015.08.003
De Angelis, Roberta, et al. "Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000-2007: Results of EUROCARE-5 population-based study." European journal of cancer (Oxford, England : 1990) vol. 51,15 (2015): 2254-2268. doi: https://doi.org/10.1016/j.ejca.2015.08.003
De Angelis R, Minicozzi P, Sant M, Dal Maso L, Brewster DH, Osca-Gelis G, Visser O, Maynadié M, Marcos-Gragera R, Troussard X, Agius D, Roazzi P, Meneghini E, Monnereau A. Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000-2007: Results of EUROCARE-5 population-based study. Eur J Cancer. 2015 Oct;51(15):2254-2268. doi: 10.1016/j.ejca.2015.08.003. Epub 2015 Sep 26. PMID: 26421827.
Copy Download .nbib Format: NLM
Effect of unilateral ovariectomy, gonadotropin stimulation and immunization against a synthetic peptide of the inhibin alpha-subunit on follicular development and oocyte recovery in cattle.

Theriogenology

Rocha A, Broussard J, Blair RM, Lim JM, Meintjes M, Roussel JD, Godke RA, Hansel W.
PMID: 16727926
Theriogenology. 1996 Sep;46(4):605-16. doi: 10.1016/0093-691X(96)00212-9.

Nulliparous Holstein cows were randomly distributed among 4 treatment groups to test the effects of treatments, including unilateral ovariectomy, anti-inhibin immunization and gonadotropin stimulation on ovarian follicle population and oocyte recovery. The Control treatment consisted of intact cows (I-Control)....

Cite
Rocha A, Broussard J, Blair RM, et al. Effect of unilateral ovariectomy, gonadotropin stimulation and immunization against a synthetic peptide of the inhibin alpha-subunit on follicular development and oocyte recovery in cattle. Theriogenology. 1996;46(4):605-16doi: 10.1016/0093-691X(96)00212-9.
Rocha, A., Broussard, J., Blair, R. M., Lim, J. M., Meintjes, M., Roussel, J. D., Godke, R. A., & Hansel, W. (1996). Effect of unilateral ovariectomy, gonadotropin stimulation and immunization against a synthetic peptide of the inhibin alpha-subunit on follicular development and oocyte recovery in cattle. Theriogenology, 46(4), 605-16. https://doi.org/10.1016/0093-691X(96)00212-9
Rocha, A, et al. "Effect of unilateral ovariectomy, gonadotropin stimulation and immunization against a synthetic peptide of the inhibin alpha-subunit on follicular development and oocyte recovery in cattle." Theriogenology vol. 46,4 (1996): 605-16. doi: https://doi.org/10.1016/0093-691X(96)00212-9
Rocha A, Broussard J, Blair RM, Lim JM, Meintjes M, Roussel JD, Godke RA, Hansel W. Effect of unilateral ovariectomy, gonadotropin stimulation and immunization against a synthetic peptide of the inhibin alpha-subunit on follicular development and oocyte recovery in cattle. Theriogenology. 1996 Sep;46(4):605-16. doi: 10.1016/0093-691X(96)00212-9. PMID: 16727926.
Copy Download .nbib Format: NLM
John adriani banned from FDA by pharmaceutical industry: an historical vignette and cartoon.

The Ochsner journal

Broussard D, Yajnik A.
PMID: 21603327
Ochsner J. 2011;11(1):10-1.

In 1969, Food and Drug Administration Commissioner Herbert Ley offered New Orleans anesthesiologist John Adriani, MD, the role of director of the Bureau of Medicine. Dr Adriani accepted the offer, but it was quickly withdrawn, in part based on...

Cite
Broussard D, Yajnik A. John adriani banned from FDA by pharmaceutical industry: an historical vignette and cartoon. Ochsner J. 2011;11(1):10-1
Broussard, D., & Yajnik, A. (2011). John adriani banned from FDA by pharmaceutical industry: an historical vignette and cartoon. The Ochsner journal, 11(1), 10-1.
Broussard, David, and Yajnik, Amit. "John adriani banned from FDA by pharmaceutical industry: an historical vignette and cartoon." The Ochsner journal vol. 11,1 (2011): 10-1.
Broussard D, Yajnik A. John adriani banned from FDA by pharmaceutical industry: an historical vignette and cartoon. Ochsner J. 2011;11(1):10-1. PMID: 21603327; PMCID: PMC3096171.
Copy Download .nbib Format: NLM
A case of Nocardia transvalensis pneumonia in a 19-year-old cystic fibrosis patient.

Lung India : official organ of Indian Chest Society

Aravantagi A, Patra KP, Broussard M, Jones K.
PMID: 22919172
Lung India. 2012 Jul;29(3):283-5. doi: 10.4103/0970-2113.99121.

Nocardia species is rarely encountered in cystic fibrosis (CF) patients. Its isolation usually implies colonization. Of all other Nocardia species, Nocardia transvalensis is very unusual and is clinically distinguishable because of its resistance to aminoglycosides, a standard antinocardial therapy....

Cite
Aravantagi A, Patra KP, Broussard M, et al. A case of Nocardia transvalensis pneumonia in a 19-year-old cystic fibrosis patient. Lung India. 2012;29(3):283-5doi: 10.4103/0970-2113.99121.
Aravantagi, A., Patra, K. P., Broussard, M., & Jones, K. (2012). A case of Nocardia transvalensis pneumonia in a 19-year-old cystic fibrosis patient. Lung India : official organ of Indian Chest Society, 29(3), 283-5. https://doi.org/10.4103/0970-2113.99121
Aravantagi, Avinash, et al. "A case of Nocardia transvalensis pneumonia in a 19-year-old cystic fibrosis patient." Lung India : official organ of Indian Chest Society vol. 29,3 (2012): 283-5. doi: https://doi.org/10.4103/0970-2113.99121
Aravantagi A, Patra KP, Broussard M, Jones K. A case of Nocardia transvalensis pneumonia in a 19-year-old cystic fibrosis patient. Lung India. 2012 Jul;29(3):283-5. doi: 10.4103/0970-2113.99121. PMID: 22919172; PMCID: PMC3424872.
Copy Download .nbib Format: NLM
The Genome of the Beluga Whale (Delphinapterus leucas).

Genes

Jones SJM, Taylor GA, Chan S, Warren RL, Hammond SA, Bilobram S, Mordecai G, Suttle CA, Miller KM, Schulze A, Chan AM, Jones SJ, Tse K, Li I, Cheung D, Mungall KL, Choo C, Ally A, Dhalla N, Tam AKY, Troussard A, Kirk H, Pandoh P, Paulino D, Coope RJN, Mungall AJ, Moore R, Zhao Y, Birol I, Ma Y, Marra M, Haulena M.
PMID: 29232881
Genes (Basel). 2017 Dec 11;8(12). doi: 10.3390/genes8120378.

The beluga whale is a cetacean that inhabits arctic and subarctic regions, and is the only living member of the genus

Cite
Jones SJM, Taylor GA, Chan S, et al. The Genome of the Beluga Whale (Delphinapterus leucas). Genes (Basel). 2017;8(12)doi: 10.3390/genes8120378.
Jones, S. J. M., Taylor, G. A., Chan, S., Warren, R. L., Hammond, S. A., Bilobram, S., Mordecai, G., Suttle, C. A., Miller, K. M., Schulze, A., Chan, A. M., Jones, S. J., Tse, K., Li, I., Cheung, D., Mungall, K. L., Choo, C., Ally, A., Dhalla, N., Tam, A. K. Y., Troussard, A., Kirk, H., Pandoh, P., Paulino, D., Coope, R. J. N., Mungall, A. J., Moore, R., Zhao, Y., Birol, I., Ma, Y., Marra, M., & Haulena, M. (2017). The Genome of the Beluga Whale (Delphinapterus leucas). Genes, 8(12), . https://doi.org/10.3390/genes8120378
Jones, Steven J M, et al. "The Genome of the Beluga Whale (Delphinapterus leucas)." Genes vol. 8,12 (2017). doi: https://doi.org/10.3390/genes8120378
Jones SJM, Taylor GA, Chan S, Warren RL, Hammond SA, Bilobram S, Mordecai G, Suttle CA, Miller KM, Schulze A, Chan AM, Jones SJ, Tse K, Li I, Cheung D, Mungall KL, Choo C, Ally A, Dhalla N, Tam AKY, Troussard A, Kirk H, Pandoh P, Paulino D, Coope RJN, Mungall AJ, Moore R, Zhao Y, Birol I, Ma Y, Marra M, Haulena M. The Genome of the Beluga Whale (Delphinapterus leucas). Genes (Basel). 2017 Dec 11;8(12). doi: 10.3390/genes8120378. PMID: 29232881; PMCID: PMC5748696.
Copy Download .nbib Format: NLM
Melanoma Cell Death Mechanisms.

Chonnam medical journal

Broussard L, Howland A, Ryu S, Song K, Norris D, Armstrong CA, Song PI.
PMID: 30288368
Chonnam Med J. 2018 Sep;54(3):135-142. doi: 10.4068/cmj.2018.54.3.135. Epub 2018 Sep 27.

Over recent years, several new molecular and immunogenic therapeutic approaches to melanoma treatment have been approved and implemented in clinical practice. Mechanisms of resistance to these new therapies have become a major problem. Mutation-specific pharmacotherapy can result in simultaneous...

Cite
Broussard L, Howland A, Ryu S, et al. Melanoma Cell Death Mechanisms. Chonnam Med J. 2018;54(3):135-142doi: 10.4068/cmj.2018.54.3.135.
Broussard, L., Howland, A., Ryu, S., Song, K., Norris, D., Armstrong, C. A., & Song, P. I. (2018). Melanoma Cell Death Mechanisms. Chonnam medical journal, 54(3), 135-142. https://doi.org/10.4068/cmj.2018.54.3.135
Broussard, Lindsey, et al. "Melanoma Cell Death Mechanisms." Chonnam medical journal vol. 54,3 (2018): 135-142. doi: https://doi.org/10.4068/cmj.2018.54.3.135
Broussard L, Howland A, Ryu S, Song K, Norris D, Armstrong CA, Song PI. Melanoma Cell Death Mechanisms. Chonnam Med J. 2018 Sep;54(3):135-142. doi: 10.4068/cmj.2018.54.3.135. Epub 2018 Sep 27. PMID: 30288368; PMCID: PMC6165917.
Copy Download .nbib Format: NLM
Erratum: Functional imaging of neuron-astrocyte interactions in a compartmentalized microfluidic device.

Microsystems & nanoengineering

Gao Y, Broussard J, Haque A, Revzin A, Tian L.
PMID: 31063160
Microsyst Nanoeng. 2016 Mar 24;2:16014. doi: 10.1038/micronano.2016.14. eCollection 2016.

[This corrects the article DOI: 10.1038/micronano.2015.45.].

Cite
Gao Y, Broussard J, Haque A, et al. Erratum: Functional imaging of neuron-astrocyte interactions in a compartmentalized microfluidic device. Microsyst Nanoeng. 2016;2:16014doi: 10.1038/micronano.2016.14.
Gao, Y., Broussard, J., Haque, A., Revzin, A., & Tian, L. (2016). Erratum: Functional imaging of neuron-astrocyte interactions in a compartmentalized microfluidic device. Microsystems & nanoengineering, 216014. https://doi.org/10.1038/micronano.2016.14
Gao, Yandong, et al. "Erratum: Functional imaging of neuron-astrocyte interactions in a compartmentalized microfluidic device." Microsystems & nanoengineering vol. 2 (2016): 16014. doi: https://doi.org/10.1038/micronano.2016.14
Gao Y, Broussard J, Haque A, Revzin A, Tian L. Erratum: Functional imaging of neuron-astrocyte interactions in a compartmentalized microfluidic device. Microsyst Nanoeng. 2016 Mar 24;2:16014. doi: 10.1038/micronano.2016.14. eCollection 2016. PMID: 31063160; PMCID: PMC6444724.
Copy Download .nbib Format: NLM
Second- or third-generation tyrosine kinase inhibitors in first-line treatment of chronic myeloid leukemia in general population: Is there a real benefit?.

Cancer medicine

Canet J, Cony-Makhoul P, Orazio S, Cornet E, Troussard X, Maynadié M, Étienne G, Monnereau A.
PMID: 34551198
Cancer Med. 2021 Oct;10(20):6959-6970. doi: 10.1002/cam4.4186. Epub 2021 Sep 22.

INTRODUCTION: Since 2009, multiple randomized trials have shown faster and deeper responses in CML patients treated with new-generation TKI (NG-TKI) compared to those treated with imatinib (IM). Are the same results observed in the general population?MATERIALS AND METHODS: Patients...

Cite
Canet J, Cony-Makhoul P, Orazio S, et al. Second- or third-generation tyrosine kinase inhibitors in first-line treatment of chronic myeloid leukemia in general population: Is there a real benefit?. Cancer Med. 2021;10(20):6959-6970doi: 10.1002/cam4.4186.
Canet, J., Cony-Makhoul, P., Orazio, S., Cornet, E., Troussard, X., Maynadié, M., Étienne, G., & Monnereau, A. (2021). Second- or third-generation tyrosine kinase inhibitors in first-line treatment of chronic myeloid leukemia in general population: Is there a real benefit?. Cancer medicine, 10(20), 6959-6970. https://doi.org/10.1002/cam4.4186
Canet, Jim, et al. "Second- or third-generation tyrosine kinase inhibitors in first-line treatment of chronic myeloid leukemia in general population: Is there a real benefit?." Cancer medicine vol. 10,20 (2021): 6959-6970. doi: https://doi.org/10.1002/cam4.4186
Canet J, Cony-Makhoul P, Orazio S, Cornet E, Troussard X, Maynadié M, Étienne G, Monnereau A. Second- or third-generation tyrosine kinase inhibitors in first-line treatment of chronic myeloid leukemia in general population: Is there a real benefit?. Cancer Med. 2021 Oct;10(20):6959-6970. doi: 10.1002/cam4.4186. Epub 2021 Sep 22. PMID: 34551198; PMCID: PMC8525157.
Copy Download .nbib Format: NLM
Humoral response to mRNA anti-COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemia.

Blood advances

Bagacean C, Letestu R, Al-Nawakil C, Brichler S, Lévy V, Sritharan N, Delmer AJ, Dartigeas C, Leblond V, Roos-Weil D, Tomowiak C, Merabet F, Béné MC, Clavert A, Chaoui D, Genet P, Guieze R, Laribi K, Drénou B, Willems L, Puppinck C, Legendre H, Troussard X, Malartre S, Cymbalista F, Michallet AS.
PMID: 34844264
Blood Adv. 2021 Nov 29; doi: 10.1182/bloodadvances.2021006215. Epub 2021 Nov 29.

Immunocompromised individuals such as chronic lymphocytic leukemia (CLL) patients are at risk of impaired immune responses to vaccination. The objective of our study was to evaluate SARS-CoV-2-specific antibody responses in CLL patients, after the first, second and third doses...

Cite
Bagacean C, Letestu R, Al-Nawakil C, et al. Humoral response to mRNA anti-COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemia. Blood Adv. 2021;doi: 10.1182/bloodadvances.2021006215.
Bagacean, C., Letestu, R., Al-Nawakil, C., Brichler, S., Lévy, V., Sritharan, N., Delmer, A. J., Dartigeas, C., Leblond, V., Roos-Weil, D., Tomowiak, C., Merabet, F., Béné, M. C., Clavert, A., Chaoui, D., Genet, P., Guieze, R., Laribi, K., Drénou, B., Willems, L., Puppinck, C., Legendre, H., Troussard, X., Malartre, S., Cymbalista, F., & Michallet, A. S. (2021). Humoral response to mRNA anti-COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemia. Blood advances, . https://doi.org/10.1182/bloodadvances.2021006215
Bagacean, Cristina, et al. "Humoral response to mRNA anti-COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemia." Blood advances vol. (2021). doi: https://doi.org/10.1182/bloodadvances.2021006215
Bagacean C, Letestu R, Al-Nawakil C, Brichler S, Lévy V, Sritharan N, Delmer AJ, Dartigeas C, Leblond V, Roos-Weil D, Tomowiak C, Merabet F, Béné MC, Clavert A, Chaoui D, Genet P, Guieze R, Laribi K, Drénou B, Willems L, Puppinck C, Legendre H, Troussard X, Malartre S, Cymbalista F, Michallet AS. Humoral response to mRNA anti-COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemia. Blood Adv. 2021 Nov 29; doi: 10.1182/bloodadvances.2021006215. Epub 2021 Nov 29. PMID: 34844264; PMCID: PMC8632355.
Copy Download .nbib Format: NLM
Using the Theory of Planned Behavior to Understand How Crisis Intervention Team (CIT) Training Facilitates Police Officers' Mental Health Referrals.

Community mental health journal

Compton MT, Krishan S, Broussard B, Bakeman R, Fleischmann MH, Hankerson-Dyson D, Husbands L, Stewart T, D'Orio B, Del Pozo B, Watson AC.
PMID: 34812962
Community Ment Health J. 2021 Nov 23; doi: 10.1007/s10597-021-00920-8. Epub 2021 Nov 23.

The Theory of Planned Behavior posits that behaviors are predicted by one's intention to perform them; intention is driven by attitude toward the behavior, subjective norm, and perceived behavioral control. We used this theory to predict Crisis Intervention Team...

Cite
Compton MT, Krishan S, Broussard B, et al. Using the Theory of Planned Behavior to Understand How Crisis Intervention Team (CIT) Training Facilitates Police Officers' Mental Health Referrals. Community Ment Health J. 2021;doi: 10.1007/s10597-021-00920-8.
Compton, M. T., Krishan, S., Broussard, B., Bakeman, R., Fleischmann, M. H., Hankerson-Dyson, D., Husbands, L., Stewart, T., D'Orio, B., Del Pozo, B., & Watson, A. C. (2021). Using the Theory of Planned Behavior to Understand How Crisis Intervention Team (CIT) Training Facilitates Police Officers' Mental Health Referrals. Community mental health journal, . https://doi.org/10.1007/s10597-021-00920-8
Compton, Michael T, et al. "Using the Theory of Planned Behavior to Understand How Crisis Intervention Team (CIT) Training Facilitates Police Officers' Mental Health Referrals." Community mental health journal vol. (2021). doi: https://doi.org/10.1007/s10597-021-00920-8
Compton MT, Krishan S, Broussard B, Bakeman R, Fleischmann MH, Hankerson-Dyson D, Husbands L, Stewart T, D'Orio B, Del Pozo B, Watson AC. Using the Theory of Planned Behavior to Understand How Crisis Intervention Team (CIT) Training Facilitates Police Officers' Mental Health Referrals. Community Ment Health J. 2021 Nov 23; doi: 10.1007/s10597-021-00920-8. Epub 2021 Nov 23. PMID: 34812962.
Copy Download .nbib Format: NLM
Diagnosis and Treatment of Chronic Lymphocytic Leukemia: Recommendations of the French CLL Study Group (FILO).

HemaSphere

Quinquenel A, Aurran-Schleinitz T, Clavert A, Cymbalista F, Dartigeas C, Davi F, de Guibert S, Delmer A, Dilhuydy MS, Feugier P, Fornecker LM, Ghez D, Guieze R, Laribi K, Leblond V, Leprêtre S, Letestu R, Lévy V, Nguyen-Khac F, Michallet AS, Tomowiak C, Tournilhac O, Ysebaert L, Troussard X.
PMID: 33062946
Hemasphere. 2020 Sep 23;4(5):e473. doi: 10.1097/HS9.0000000000000473. eCollection 2020 Oct.

As a result of significant recent developments, the management of patients with chronic lymphocytic leukemia (CLL) is changing, and new therapeutic options will continue to emerge in the near future. The recommendations of the French Innovative Leukemia Organization (FILO-CLL)...

Cite
Quinquenel A, Aurran-Schleinitz T, Clavert A, et al. Diagnosis and Treatment of Chronic Lymphocytic Leukemia: Recommendations of the French CLL Study Group (FILO). Hemasphere. 2020;4(5):e473doi: 10.1097/HS9.0000000000000473.
Quinquenel, A., Aurran-Schleinitz, T., Clavert, A., Cymbalista, F., Dartigeas, C., Davi, F., de Guibert, S., Delmer, A., Dilhuydy, M. S., Feugier, P., Fornecker, L. M., Ghez, D., Guieze, R., Laribi, K., Leblond, V., Leprêtre, S., Letestu, R., Lévy, V., Nguyen-Khac, F., Michallet, A. S., Tomowiak, C., Tournilhac, O., Ysebaert, L., & Troussard, X. (2020). Diagnosis and Treatment of Chronic Lymphocytic Leukemia: Recommendations of the French CLL Study Group (FILO). HemaSphere, 4(5), e473. https://doi.org/10.1097/HS9.0000000000000473
Quinquenel, Anne, et al. "Diagnosis and Treatment of Chronic Lymphocytic Leukemia: Recommendations of the French CLL Study Group (FILO)." HemaSphere vol. 4,5 (2020): e473. doi: https://doi.org/10.1097/HS9.0000000000000473
Quinquenel A, Aurran-Schleinitz T, Clavert A, Cymbalista F, Dartigeas C, Davi F, de Guibert S, Delmer A, Dilhuydy MS, Feugier P, Fornecker LM, Ghez D, Guieze R, Laribi K, Leblond V, Leprêtre S, Letestu R, Lévy V, Nguyen-Khac F, Michallet AS, Tomowiak C, Tournilhac O, Ysebaert L, Troussard X. Diagnosis and Treatment of Chronic Lymphocytic Leukemia: Recommendations of the French CLL Study Group (FILO). Hemasphere. 2020 Sep 23;4(5):e473. doi: 10.1097/HS9.0000000000000473. eCollection 2020 Oct. PMID: 33062946; PMCID: PMC7523785.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 81 entries